# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-265800
Filing Date
2025-11-05
Accepted
2025-11-05 08:00:41
Documents
49
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | nams-20251105.htm iXBRL | 8-K | 62530
2 | EX-99.1 | nams-ex99_1.htm | EX-99.1 | 705377
3 | EX-99.2 | nams-ex99_2.htm | EX-99.2 | 51068
4 | GRAPHIC | nams-ex99_2s1.jpg | GRAPHIC | 347091
5 | GRAPHIC | nams-ex99_2s2.jpg | GRAPHIC | 951364
6 | GRAPHIC | nams-ex99_2s3.jpg | GRAPHIC | 479118
7 | GRAPHIC | nams-ex99_2s4.jpg | GRAPHIC | 306397
8 | GRAPHIC | nams-ex99_2s5.jpg | GRAPHIC | 346381
9 | GRAPHIC | nams-ex99_2s6.jpg | GRAPHIC | 152981
10 | GRAPHIC | nams-ex99_2s7.jpg | GRAPHIC | 209933
11 | GRAPHIC | nams-ex99_2s8.jpg | GRAPHIC | 517313
12 | GRAPHIC | nams-ex99_2s9.jpg | GRAPHIC | 364537
13 | GRAPHIC | nams-ex99_2s10.jpg | GRAPHIC | 327094
14 | GRAPHIC | nams-ex99_2s11.jpg | GRAPHIC | 298104
15 | GRAPHIC | nams-ex99_2s12.jpg | GRAPHIC | 327725
16 | GRAPHIC | nams-ex99_2s13.jpg | GRAPHIC | 350594
17 | GRAPHIC | nams-ex99_2s14.jpg | GRAPHIC | 289953
18 | GRAPHIC | nams-ex99_2s15.jpg | GRAPHIC | 375250
19 | GRAPHIC | nams-ex99_2s16.jpg | GRAPHIC | 341949
20 | GRAPHIC | nams-ex99_2s17.jpg | GRAPHIC | 337854
21 | GRAPHIC | nams-ex99_2s18.jpg | GRAPHIC | 241303
22 | GRAPHIC | nams-ex99_2s19.jpg | GRAPHIC | 239061
23 | GRAPHIC | nams-ex99_2s20.jpg | GRAPHIC | 403685
24 | GRAPHIC | nams-ex99_2s21.jpg | GRAPHIC | 310502
25 | GRAPHIC | nams-ex99_2s22.jpg | GRAPHIC | 332631
26 | GRAPHIC | nams-ex99_2s23.jpg | GRAPHIC | 457813
27 | GRAPHIC | nams-ex99_2s24.jpg | GRAPHIC | 327871
28 | GRAPHIC | nams-ex99_2s25.jpg | GRAPHIC | 407234
29 | GRAPHIC | nams-ex99_2s26.jpg | GRAPHIC | 321728
30 | GRAPHIC | nams-ex99_2s27.jpg | GRAPHIC | 313143
31 | GRAPHIC | nams-ex99_2s28.jpg | GRAPHIC | 312647
32 | GRAPHIC | nams-ex99_2s29.jpg | GRAPHIC | 414398
33 | GRAPHIC | nams-ex99_2s30.jpg | GRAPHIC | 369882
34 | GRAPHIC | nams-ex99_2s31.jpg | GRAPHIC | 305003
35 | GRAPHIC | nams-ex99_2s32.jpg | GRAPHIC | 442643
36 | GRAPHIC | nams-ex99_2s33.jpg | GRAPHIC | 349282
37 | GRAPHIC | nams-ex99_2s34.jpg | GRAPHIC | 358469
38 | GRAPHIC | nams-ex99_2s35.jpg | GRAPHIC | 301784
39 | GRAPHIC | nams-ex99_2s36.jpg | GRAPHIC | 332042
40 | GRAPHIC | nams-ex99_2s37.jpg | GRAPHIC | 293404
| Complete submission text file | 0001193125-25-265800.txt |  | 19139535

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
41 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nams-20251105.xsd | EX-101.SCH | 55020
51 | EXTRACTED XBRL INSTANCE DOCUMENT | nams-20251105_htm.xml | XML | 6274

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 251451861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)